Facebook
Twitter
Telegram
Report an ErrorCross Country Healthcare Balance Sheet 2011-2024 | CCRN
Annual Balance Sheet Cross Country Healthcare
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
151 M | 185 M | 58.7 M | 93.9 M | 67.2 M | 73.6 M | 66.4 M | 87.4 M | 69.1 M | 522 K | 23.4 M | 31.4 M |
Long Term Debt |
151 M | 182 M | 55.8 M | 71 M | 77.9 M | 92.3 M | 84.8 M | 81.8 M | 70.5 M | 93.2 K | 176 K | 25 M |
Long Term Debt Current |
4.13 M | 4.09 M | 4.51 M | 4.88 M | 5.24 M | 6.88 M | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 133 M | 123 M | 135 M | 139 M | 139 M | 128 M | 42.7 M | 24.2 M | 40.3 M |
Total Current Liabilities |
272 M | 200 M | 93.4 M | 85.5 M | 85.4 M | 94.6 M | 97.1 M | 86 M | 67 M | 44.9 M | 72.6 M | 46.3 M |
Total Liabilities |
491 M | 435 M | 202 M | 219 M | 209 M | 230 M | 237 M | 225 M | 195 M | 87.6 M | 96.8 M | 86.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
166 M | -22.7 M | -155 M | -142 M | -84.1 M | -67.1 M | -104 M | -112 M | -116 M | -84.7 M | -32.7 M | 9.5 M |
Total Assets |
948 M | 733 M | 357 M | 382 M | 427 M | 468 M | 388 M | 366 M | 325 M | 248 M | 306 M | 336 M |
Cash and Cash Equivalents |
3.6 M | 1.04 M | 1.6 M | 1.03 M | 16 M | 25.5 M | 20.6 M | 2.45 M | 5 M | 8.06 M | 10.5 M | 10.6 M |
Book Value |
457 M | 298 M | 155 M | 164 M | 218 M | 238 M | 152 M | 141 M | 130 M | 161 M | 209 M | 249 M |
Total Shareholders Equity |
457 M | 298 M | 155 M | 163 M | 218 M | 237 M | 151 M | 141 M | 130 M | 161 M | 209 M | 249 M |
All numbers in USD currency
Quarterly Balance Sheet Cross Country Healthcare
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.13 M | 3.04 M | 3.15 M | 3.84 M | 4.88 M | 133 M | - | 224 M | 182 M | 103 M | 115 M | 14 M | 55.8 M | 55.8 M | 55.8 M | 15.2 M | 71 M | 70.6 M | 70.6 M | 75.5 M | 77.9 M | 77.9 M | 77.9 M | 77.9 M | 92.3 M | 92.3 M | 92.3 M | 92.3 M | 84.8 M | 70.2 M | 84.8 M | 84.8 M | 81.3 M | 81.3 M | 81.3 M | 81.3 M | 70.5 M | 70.5 M | 70.5 M | 70.5 M | 93 K | 93 K | 93 K | 93 K | 176 K | 176 K | 176 K | 176 K | 25 M | 25 M | 25 M | 25 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
180 M | 238 M | 301 M | 469 M | 491 M | 460 M | - | 560 M | 435 M | 304 M | 302 M | 269 M | 202 M | 202 M | 202 M | 202 M | 219 M | 219 M | 219 M | 219 M | 209 M | 209 M | 209 M | 209 M | 230 M | 230 M | 230 M | 230 M | 237 M | 237 M | 237 M | 237 M | 224 M | 224 M | 224 M | 224 M | 195 M | 195 M | 195 M | 195 M | 87.6 M | 87.6 M | 87.6 M | 87.6 M | 96.8 M | 96.8 M | 96.8 M | 96.8 M | 98.6 M | 86.6 M | 86.6 M | 86.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
241 M | 229 M | 217 M | 195 M | 166 M | 127 M | - | 39.2 M | -22.7 M | -100 M | -124 M | -135 M | -155 M | -155 M | -155 M | -155 M | -142 M | -142 M | -142 M | -142 M | -84.1 M | -84.1 M | -84.1 M | -84.1 M | -67.1 M | -67.1 M | -67.1 M | -67.1 M | -104 M | -104 M | -104 M | -104 M | -112 M | -112 M | -112 M | -112 M | -116 M | -116 M | -116 M | -116 M | -84.7 M | -84.7 M | -84.7 M | -84.7 M | -32.7 M | -32.7 M | -32.7 M | -32.7 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M |
Total Assets |
648 M | 708 M | 771 M | 921 M | 948 M | 883 M | - | 916 M | 733 M | 520 M | 494 M | 442 M | 357 M | 357 M | 357 M | 357 M | 382 M | 382 M | 382 M | 382 M | 427 M | 427 M | 427 M | 427 M | 468 M | 468 M | 468 M | 468 M | 388 M | 388 M | 388 M | 388 M | 366 M | 366 M | 366 M | 366 M | 325 M | 325 M | 325 M | 325 M | 248 M | 248 M | 248 M | 248 M | 306 M | 306 M | 306 M | 306 M | 348 M | 336 M | 336 M | 336 M |
Cash and Cash Equivalents |
5.24 M | 14.3 M | 673 K | 291 K | 3.6 M | 30.3 M | 279 K | 1.21 M | 1.04 M | 842 K | 18.1 M | 13.5 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.03 M | 9.46 M | 1.03 M | 1.03 M | 16 M | 28.1 M | 16 M | 16 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 2.45 M | 2.45 M | 2.45 M | 2.45 M | 5 M | 5 M | 5 M | 5 M | 8.06 M | 8.06 M | 8.06 M | 8.06 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M |
Book Value |
468 M | 470 M | 470 M | 452 M | 457 M | 423 M | - | 356 M | 298 M | 217 M | 192 M | 174 M | 155 M | 155 M | 155 M | 155 M | 164 M | 164 M | 164 M | 164 M | 218 M | 218 M | 218 M | 218 M | 238 M | 238 M | 238 M | 238 M | 152 M | 152 M | 152 M | 152 M | 141 M | 141 M | 141 M | 141 M | 130 M | 130 M | 130 M | 130 M | 161 M | 161 M | 161 M | 161 M | 209 M | 209 M | 209 M | 209 M | 249 M | 249 M | 249 M | 249 M |
Total Shareholders Equity |
468 M | 470 M | 470 M | 452 M | 457 M | 423 M | 411 M | 356 M | 298 M | 217 M | 192 M | 173 M | 154 M | 154 M | 154 M | 154 M | 163 M | 163 M | 163 M | 163 M | 218 M | 218 M | 218 M | 218 M | 237 M | 237 M | 237 M | 237 M | 151 M | 151 M | 151 M | 151 M | 141 M | 141 M | 141 M | 141 M | 130 M | 130 M | 130 M | 130 M | 161 M | 161 M | 161 M | 161 M | 209 M | 209 M | 209 M | 209 M | 249 M | 249 M | 249 M | 249 M |
All numbers in USD currency